Rossari Biotech Ltd
NSE:ROSSARI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
534.75
819.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ROSSARI
stock under the Base Case scenario is
1 113.03
INR.
Compared to the current market price of 534.75 INR,
Rossari Biotech Ltd
is
Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Rossari Biotech Ltd.
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
|
| CH |
|
Sika AG
F:SIKA
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Rossari Biotech Ltd
Balance Sheet Decomposition
Rossari Biotech Ltd
| Current Assets | 11.1B |
| Cash & Short-Term Investments | 767.9m |
| Receivables | 5.4B |
| Other Current Assets | 5B |
| Non-Current Assets | 9.7B |
| Long-Term Investments | 923.7m |
| PP&E | 6.2B |
| Intangibles | 2.3B |
| Other Non-Current Assets | 307.8m |
| Current Liabilities | 6.4B |
| Accounts Payable | 2.9B |
| Other Current Liabilities | 3.5B |
| Non-Current Liabilities | 1.9B |
| Long-Term Debt | 1.4B |
| Other Non-Current Liabilities | 523.1m |
Free Cash Flow Analysis
Rossari Biotech Ltd
| INR | |
| Free Cash Flow | INR |
Earnings Waterfall
Rossari Biotech Ltd
|
Revenue
|
22.2B
INR
|
|
Cost of Revenue
|
-15.2B
INR
|
|
Gross Profit
|
7B
INR
|
|
Operating Expenses
|
-5B
INR
|
|
Operating Income
|
2B
INR
|
|
Other Expenses
|
-649m
INR
|
|
Net Income
|
1.4B
INR
|
ROSSARI Profitability Score
Profitability Due Diligence
Rossari Biotech Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Rossari Biotech Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
ROSSARI Solvency Score
Solvency Due Diligence
Rossari Biotech Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Rossari Biotech Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ROSSARI Price Targets Summary
Rossari Biotech Ltd
According to Wall Street analysts, the average 1-year price target for
ROSSARI
is 828.85 INR
with a low forecast of 757.5 INR and a high forecast of 924 INR.
Dividends
Current shareholder yield for
ROSSARI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ROSSARI
stock under the Base Case scenario is
1 113.03
INR.
Compared to the current market price of 534.75 INR,
Rossari Biotech Ltd
is
Undervalued by 52%.